$UXIN

Dai Kun purchased $13K of UXIN (indirect holdings)

Dai Kun (Chief Executive Officer) purchased 11,836 indirectly-held shares of Uxin Ltd (UXIN) at $1.13 on 2026-10-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Dai Kun
Published Oct 9, 2026, 1:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 1:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$UXIN
Neutral
high confidence
Mentioned
$UXIN
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UXINNeutralLow
01

Why it matters

The filing provides a fresh data point on insider ownership but is too small to affect price materially.

02

Market read

A modest insider purchase that adds a small amount to the CEO's holdings; limited trading relevance.

03

What to watch

Potential upcoming corporate actions or market conditions not disclosed could influence the relevance of this buy.

Relevance 2/10Novelty 2/10Timing: today (filing date 2026‑10‑09)

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$UXINNeutralHigh confidence
Context

CEO Dai Kun bought 11,836 shares for $13.3K via a 10b5‑1 plan, increasing his stake to 63,602 shares.

Expected impact

slight upward pressure as market prices in the insider buy

Evidence & confidence

The transaction size is modest ($13K) and unlikely to move the stock materially, but insider buying is generally viewed positively.

Market effects

No immediate sector impact; the filing is isolated to Uxin.

Minimal effect on Chinese or U.S. markets.

Low; only relevant to investors tracking Uxin.

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a strong confidence signal.

Key entities

  • Dai Kun

    Chief Executive Officer of Uxin Ltd.

  • Uxin Ltd

    Chinese ride‑hailing platform listed on NYSE under ticker UXIN.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UXINMedAI 8/10

Uxin (UXIN) Q2 2026 Earnings Call Transcript

Uxin (UXIN) reported Q2 2026 revenue of RMB 1.51B, up 75% YoY, with retail volume up 89% and wholesale volume up 88%. Gross margin turned negative at -0.7% due to inventory adjustments. Q3 guidance: 20,500-21,000 retail units, RMB 1.16B-1.19B revenue, and >6% gross margin. CEO plans $5M share purchase. Industry consolidation expected, with 50,000-60,000 dealerships forecast to exit by year-end.

$UXINMed

Uxin Q2 Loss Widens; Shares Up

Uxin Limited reported a wider net loss of RMB 183.33 million ($27.02 million) in Q2 2026, up from RMB 73.80 million a year ago, with total revenues increasing to RMB 1.151 billion ($169.66 million). The company forecasted Q3 revenue of RMB 1.16-1.19 billion and a gross profit margin above 6.0%. Shares rose 13.30% to $1.2350 on Nasdaq.

$UXINMed

Uxin Ltd (UXIN): Financial results for Q2 2026

Uxin Ltd (UXIN) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2026 BEIJING, September 24, 2026 – Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), China’s leading used car retailer, today announced its unaudited financial results for the quarter ended

$UXINMed

Why is Uxin stock surging today?

Uxin (UXIN) stock rose 6.42% in pre-market trading after reporting Q2 2026 revenue of RMB1,151.2 million, up 74.9% YoY. The company projected Q3 revenue of RMB1,160-1,190 million and a gross profit margin above 6.0%, reversing a prior -0.7% margin. Management attributed margin weakness to temporary market conditions. The rally occurred despite broader market declines, highlighting company-specific optimism.

$UXINMed

Uxin Q1 Earnings Call Highlights

Uxin (NASDAQ: UXIN) reported Q1 adjusted EBITDA loss of CNY 34.3 million, widening sequentially from CNY 27.2 million, which management attributed to Chinese New Year seasonality and higher ramp-up and staffing costs. Management cited auto-market weakness: first five months’ new vehicle sales down 20% YoY and April-May ICE sales down over 35% YoY, with used ICE prices falling 10%-15% in 1-2 months. Uxin said gross margin may face more pressure in Q2, but expects improvement in Q3 if ICE prices s